A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The FL-100 transcranial direct-current stimulation (tDCS) system (Flow Neuroscience) ...

tDCS treatment significantly improves depressive symptoms and boosts clinical response and remission rates, with no serious device-related adverse events reported. Study: Home-based transcranial ...

The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...

An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the Food and Drug Administration, in what medical experts consider a milestone ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...

A headset that stimulates the brain with electricity is able to relieve symptoms of major depression in 57.5% of patients, a new trial has found. Researchers at Kings College London studied 174 ...

While devices that stimulate the brain invasively have generally been available since 2002, and devices that do so non-invasively have been available since 2013, in recent years, the U.S. Food and ...